Evexia Lifecare
BSE: EVEXIA · Trading - Chemicals
Snapshot
Unlock Evexia Lifecare's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Evexia Lifecare Limited is an Indian company based in Vadodara that engages in the trading and manufacturing of chemical, pharmaceutical, and agricultural products. The company has diversified its operations into healthcare services, edible oils, plastic granules, and is currently expanding into the e-mobility and specialty chemicals sectors.
Business Model
The company generates revenue through a diversified trading and manufacturing model, supplying chemical and pharmaceutical intermediates alongside agricultural produce and consumer goods. It leverages its manufacturing facilities in Gujarat to serve both domestic and international markets.
Management Commentary
Management is actively pivoting the company towards high-growth sectors such as specialty chemicals and e-mobility to enhance long-term value. The strategy focuses on portfolio diversification to reduce reliance on traditional trading segments.
Growth Outlook
Future growth is expected to be driven by the expansion into the e-mobility sector and the development of specialty chemical production capabilities. The company continues to invest in healthcare and laboratory testing services to broaden its revenue streams.
Key Risks
- Commodity Price Volatility. Fluctuations in the prices of chemicals, agricultural produce, and edible oils can significantly impact profit margins.
- Execution Risk. The company's aggressive diversification into new sectors like e-mobility may face challenges related to capital allocation and operational integration.
- Regulatory Compliance. Operating in the pharmaceutical and chemical sectors requires strict adherence to evolving environmental and safety regulations.
- Market Competition. The trading and manufacturing segments are highly competitive, which may exert pressure on pricing and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Evexia Lifecare and 5,000+ companies — free.
Key Metrics
REVENUE
₹110 Cr
TTM · consolidated
NET PROFIT
₹2 Cr
TTM · consolidated
EPS
₹0.03
TTM · consolidated
RETURN ON EQUITY
0.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
0.3%
TTM · consolidated
P/E
67.0x
Q4 FY26 · consolidated
EV/EBITDA
105.6x
Q4 FY26 · consolidated
EBITDA MARGIN
3.0%
TTM · consolidated
NET PROFIT MARGIN
2.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
Peers · Trading - Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Evexia LifecareEVEXIA | ₹351 Cr | 67.00 | 105.58 | 16.2% | 3.0% | 0.5% | 0.3% | +3.6% |
Uniphos Enterprises LimitedUNIENTER | ₹633 Cr | 25.52 | 25.51 | -77.1% | 92.7% | 0.9% | 0.9% | -41.6% |
Vinyl Chemicals (India) LimitedVINYLINDIA | ₹406 Cr | 21.04 | 16.00 | -3.2% | 4.2% | 14.5% | 19.4% | -24.5% |
A-1 LimitedA1L | ₹287 Cr | 23.79 | 19.80 | 38.7% | 3.7% | 16.5% | 26.0% | -99.4% |
As of Q4 FY26
Financials
Evexia Lifecare
BSE: EVEXIA · Trading - Chemicals
Snapshot
Unlock Evexia Lifecare's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Evexia Lifecare Limited is an Indian company based in Vadodara that engages in the trading and manufacturing of chemical, pharmaceutical, and agricultural products. The company has diversified its operations into healthcare services, edible oils, plastic granules, and is currently expanding into the e-mobility and specialty chemicals sectors.
Business Model
The company generates revenue through a diversified trading and manufacturing model, supplying chemical and pharmaceutical intermediates alongside agricultural produce and consumer goods. It leverages its manufacturing facilities in Gujarat to serve both domestic and international markets.
Management Commentary
Management is actively pivoting the company towards high-growth sectors such as specialty chemicals and e-mobility to enhance long-term value. The strategy focuses on portfolio diversification to reduce reliance on traditional trading segments.
Growth Outlook
Future growth is expected to be driven by the expansion into the e-mobility sector and the development of specialty chemical production capabilities. The company continues to invest in healthcare and laboratory testing services to broaden its revenue streams.
Key Risks
- Commodity Price Volatility. Fluctuations in the prices of chemicals, agricultural produce, and edible oils can significantly impact profit margins.
- Execution Risk. The company's aggressive diversification into new sectors like e-mobility may face challenges related to capital allocation and operational integration.
- Regulatory Compliance. Operating in the pharmaceutical and chemical sectors requires strict adherence to evolving environmental and safety regulations.
- Market Competition. The trading and manufacturing segments are highly competitive, which may exert pressure on pricing and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Evexia Lifecare and 5,000+ companies — free.
Key Metrics
REVENUE
₹110 Cr
TTM · consolidated
NET PROFIT
₹2 Cr
TTM · consolidated
EPS
₹0.03
TTM · consolidated
RETURN ON EQUITY
0.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
0.3%
TTM · consolidated
P/E
67.0x
Q4 FY26 · consolidated
EV/EBITDA
105.6x
Q4 FY26 · consolidated
EBITDA MARGIN
3.0%
TTM · consolidated
NET PROFIT MARGIN
2.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
Peers · Trading - Chemicals
As of Q4 FY26